Your browser doesn't support javascript.
loading
Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.
Madsen, Jesper J; Petersen, Jacob E; Christensen, Dan P; Hansen, Jakob B; Schwartz, Thue W; Frimurer, Thomas M; Olsen, Ole H.
Afiliação
  • Madsen JJ; Global and Planetary Health, College of Public Health, University of South Florida, Tampa, Florida, USA; Center for Global Health and Infectious Diseases Research, College of Public Health, University of South Florida, Tampa, Florida, USA; Department of Molecular Medicine, Morsani College of Medicin
  • Petersen JE; Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Christensen DP; Embark Biotech ApS, Copenhagen, Denmark.
  • Hansen JB; Embark Biotech ApS, Copenhagen, Denmark.
  • Schwartz TW; Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Frimurer TM; Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Olsen OH; Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. Electronic address: oho@sund.ku.dk.
J Biol Chem ; 299(12): 105438, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37944618
ABSTRACT
The tachykinin receptors neurokinin 1 (NK1R) and neurokinin 2 (NK2R) are G protein-coupled receptors that bind preferentially to the natural peptide ligands substance P and neurokinin A, respectively, and have been targets for drug development. Despite sharing a common C-terminal sequence of Phe-X-Gly-Leu-Met-NH2 that helps direct biological function, the peptide ligands exhibit some degree of cross-reactivity toward each other's non-natural receptor. Here, we investigate the detailed structure-activity relationships of the ligand-bound receptor complexes that underlie both potent activation by the natural ligand and cross-reactivity. We find that the specificity and cross-reactivity of the peptide ligands can be explained by the interactions between the amino acids preceding the FxGLM consensus motif of the bound peptide ligand and two regions of the receptor the ß-hairpin of the extracellular loop 2 (ECL2) and a N-terminal segment leading into transmembrane helix 1. Positively charged sidechains of the ECL2 (R177 of NK1R and K180 of NK2R) are seen to play a vital role in the interaction. The N-terminal positions 1 to 3 of the peptide ligand are entirely dispensable. Mutated and chimeric receptor and ligand constructs neatly swap around ligand specificity as expected, validating the structure-activity hypotheses presented. These findings will help in developing improved agonists or antagonists for NK1R and NK2R.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Taquicininas / Receptores da Neurocinina-1 Limite: Animals / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Taquicininas / Receptores da Neurocinina-1 Limite: Animals / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2023 Tipo de documento: Article